Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses

Diana Ferraro1, Vincenzo G Mirante, Luisa Losi

  • 1*Neurology Unit, Department of Neurosciences ‡Pathology Institute §Gastroenterology Unit, University of Modena and Reggio Emilia †Internal Medicine and Gastroenterology Unit, Nuovo Ospedale Civile Sant'Agostino Estense, Modena, Italy.

The Neurologist
|June 16, 2015
PubMed

Insights

High-dose intravenous methylprednisolone (MP) can cause liver damage in multiple sclerosis patients. This potentially lethal adverse reaction may be more common than previously recognized.

Area of Science:

  • Neurology
  • Hepatology
  • Clinical Pharmacology

Background:

  • Intravenous methylprednisolone (MP) is a standard first-line therapy for multiple sclerosis (MS) relapses.
  • Concerns exist regarding potential liver toxicity associated with this treatment.

Observation:

  • Four multiple sclerosis patients without pre-existing liver conditions or risk factors developed elevated liver enzymes after IV MP treatment.
  • Liver biopsies in two patients revealed significant histological changes, including fibrosis and necrosis.

Findings:

  • A causal link between MP administration and hypertransaminasaemia was confirmed in one patient via rechallenge.
  • Hepatotoxicity is a potential adverse effect of high-dose intravenous MP therapy in MS patients.

Implications:

  • Increased awareness of MP-induced liver toxicity is crucial for clinicians managing MS patients.
  • Monitoring liver function may be warranted during or after corticosteroid pulse therapy.
  • This highlights the importance of reporting potentially lethal adverse drug reactions.

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
195
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
136
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
475
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
169
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
204
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
380